ICON will provide Shire with a range of services including site and country feasibility, ethics and regulatory submissions, clinical trial monitoring, project management, medical management and medical data review.
Shire will also utilize ICON Central Laboratories’ test menu from its global network of laboratories.
ICON CEO Ciaran Murray said they look forward to building on their successful relationship with Shire to help them realize efficiencies as they seek to bring new products to market.
"ICON’s success is based on the right blend of development services and global testing facilities, all of which are underpinned by robust processes and innovative technology," Murray added.